Cadila Healthcare has informed the National Stock Exchange that credit rating agency, CRISIL, has assigned a 'AA+/Stable' rating for the company's Rs 250 crores non-convertible debenture (NCD).
This rating indicates high degree of safety with regard to timely payment of interest and principal on the instrument.
Explore Business Standard